Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,380 across all filing types
Latest filing 2020-06-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
关于公司产品获得三类医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the receipt of a medical device registration certificate for a disposable infusion set with needle. It includes details about the registration certificate, product description, approval date, and potential impact on company performance. The document is short (1159 characters) and serves as a regulatory announcement about product registration and its implications, not a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management changes. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-06-02 Chinese
关于5%以上股东持股减持超过1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a shareholder's reduction in shareholding by more than 1%, specifying the details of the share reduction, dates, and percentages. It explicitly states that the change does not affect control of the company and provides detailed shareholding information before and after the change. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds (in this case, a reduction from 41.3637% to 40.3391%). The document length is short and focused solely on shareholding changes, not a full report or announcement of a report publication. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2020-06-01 Chinese
关于股东集中竞价减持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding the results of a shareholder's concentrated bidding reduction of shares. It details the shareholder's holdings before and after the reduction, the number of shares reduced, the reduction period, and confirms the completion of the reduction plan. There is no financial report, earnings data, or management discussion. The document is a notification of a change in major shareholding levels, specifically the reduction of shares by a significant shareholder below the 5% threshold. This fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a report or announcement of a report publication.
2020-05-29 Chinese
关于控股子公司获得二类医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding its controlling subsidiary obtaining Class II medical device registration certificates for medical masks. It includes details about the certificates, product specifications, and potential business impact. The document is relatively short (1636 characters) and serves as a formal notification to shareholders and the public about a regulatory approval event. It does not contain financial statements, management discussion, or detailed financial data. It is not a report, but an announcement of a specific event related to the company's operations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-27 Chinese
关于全资子公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the completion of business registration changes for its wholly-owned subsidiary. It details changes in legal representative, address, business scope, and other registration information. The document is short (1617 characters) and is an announcement of a corporate registration update, not a financial report or detailed management information. It does not contain financial data, earnings, or governance changes related to board or management personnel. It is not a report but an announcement of a corporate event related to subsidiary registration changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-26 Chinese
关于确定公司子公司2020年度远期结售汇额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the determination of the 2020 forward foreign exchange settlement quota for its subsidiary. It details the purpose, overview, period, scale, risk analysis, and risk control measures of the forward foreign exchange settlement business. The document is a formal announcement of a board decision related to financing activities (foreign exchange hedging to manage currency risk). It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or voting result. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing and risk management activities involving foreign exchange forward contracts. The document length is short (1434 characters), but it contains substantive information about the financing activity rather than just announcing a report publication or certification. Therefore, the appropriate classification is CAP with high confidence.
2020-05-22 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.